Award
National Institute on Drug Abuse 5K23DA055695-05
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: A Pilot Randomized Controlled Trial
Recipient
Rhode Island Hospital
Award Amount
$195,696.00
Ceiling
$195,696.00
Awarded
June 03, 2026
Identifier
5K23DA055695-05
NIH-funded study to assess injectable extended-release buprenorphine versus sublingual buprenorphine in incarcerated individuals, including implementation science evaluation.
Description
This NIH-funded research project aims to evaluate the effectiveness and implementation of injectable extended-release buprenorphine in correctional settings, focusing on opioid use disorder treatment among incarcerated populations. The project includes a randomized controlled trial and a process evaluation guided by implementation science frameworks.